Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.

MLA

Galloway, Sarah A. E., et al. “Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.” Frontiers in Immunology, Mar. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.3389/fimmu.2019.00319.

APA

Galloway, S. A. E., Dolton, G., Attaf, M., Wall, A., Fuller, A., Rius, C., Bianchi, V., Theaker, S., Lloyd, A., Caillaud, M. E., Svane, I. M., Donia, M., Cole, D. K., Szomolay, B., Rizkallah, P., & Sewell, A. K. (2019). Peptide Super-Agonist Enhances T-Cell Responses to Melanoma. Frontiers in Immunology, N.PAG. https://doi.org/10.3389/fimmu.2019.00319

Chicago

Galloway, Sarah A. E., Garry Dolton, Meriem Attaf, Aaron Wall, Anna Fuller, Cristina Rius, Valentina Bianchi, et al. 2019. “Peptide Super-Agonist Enhances T-Cell Responses to Melanoma.” Frontiers in Immunology, March, N.PAG. doi:10.3389/fimmu.2019.00319.